(NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, will report its financial ...
WALTHAM, Mass., July 10, 2026 /PRNewswire/ -- Q32 Bio Inc. (Nasdaq: QTTB) ("Q32 Bio"), a clinical stage biotechnology company focused on developing innovative therapies for alopecia areata ("AA") and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results